Document is current
Any future updates will be listed below
-
Authors
Dusek, Jan
Mejdrová, Ivana
Dohnalová, Klára
Smutny, Tomas
Chalupsky, Karel
Krutakova, Maria
Skoda, Josef
Rashidian, Azam
Pavkova, Ivona
Škach, Kryštof https://orcid.org/0000-0002-7558-6961
Hricová, Jana https://orcid.org/0009-0008-9369-8853
Chocholouskova, Michaela
Smutna, Lucie https://orcid.org/0000-0002-3941-4193
Kamaraj, Rajamanikkam https://orcid.org/0000-0001-7115-0178
Hroch, Miloš https://orcid.org/0000-0002-5583-2942
Leníček, Martin https://orcid.org/0000-0001-6242-3488
Mičuda, Stanislav
Pijnenburg, Dirk
van Beuningen, Rinie
Holčapek, Michal https://orcid.org/0000-0003-3978-1249
Vítek, Libor
Ingelman-Sundberg, Magnus https://orcid.org/0000-0002-7255-9079
Burk, Oliver https://orcid.org/0000-0001-8990-9656
Kronenberger, Thales https://orcid.org/0000-0001-6933-7590
Nencka, Radim https://orcid.org/0000-0001-6167-0380
Pavek, Petr https://orcid.org/0000-0001-8769-4196
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (TuCAD2 and CMIF)
- License Information
-
More Information
Article History
Received: 31 March 2024
Accepted: 20 January 2025
First Online: 6 February 2025
Competing interests
: MI-883 belongs to a novel class of heterocyclic compounds protected by the family of patent applications (WO2020221380A1 PCT) with a priority date of 25 May 2020 in Europe, Canada, the United States, and Australia (EP3962915B1, CA3129981A1, US20220185822A1, and AU2020264679A1). The Australian patent was granted (AU2020264679B2) on December 8, 2022. The inventors of the patents are Petr Pavek, Radim Nencka, Jan Dusek, and Ivana Mejdrová. Applicants are the Charles University and the Institute of Organic Chemistry and Biochemistry, the Czech Academy of Sciences. Compound MI883 has been licensed to LipidEra Therapeutics B.V., Netherlands. The remaining authors declare no competing interests.
: The research was conducted in accordance with journal policy. Co-authors were included if they met all authorship policies.
